StonvexLoading…
StonvexStonvexStonvexCore line items from CROX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.04B | $4.10B | $3.96B | $3.55B |
Operating Income | $149.51M | $1.02B | $1.04B | $850.76M |
Net Income | $-81.20M | $950.07M | $792.57M | $540.16M |
EPS (Diluted) | $-1.50 | $15.88 | $12.79 | $8.71 |
Total Assets | $4.17B | $4.81B | $4.64B | $4.50B |
Total Liabilities | $2.88B | $2.98B | $3.19B | $3.68B |
Cash & Equivalents | $130.35M | $180.49M | $149.29M | $191.63M |
Free Cash Flow OCF − CapEx | $659.20M | $923.14M | $814.82M | $498.95M |
Shares Outstanding | 50.20M | 56.50M | 60.50M | 61.70M |